Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 111 - 120 of 245 for gsk. (0.07 seconds)

GlaxoSmithKline Breathes Easier on Advair. More details...
CBT 200 Rises Another 26 points. More details...
Amgen Soars On Positive News. More details...
CBT 200 Moves Almost 40 Points Lower. More details...
CBT 200 Slides 32 Points. More details...
CBT 200 Approaches 18-Month High. More details...
CBT 200 Closes 10 Points Under 18-Month Highs. More...
Oil Companies Dominate Profits But Pharma Has Best...
CBT 200 Adds on 48 Points. More details...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital